Om

Jiangsu Hengrui Pharmaceuticals Co., Ltd. is a China-based biopharmaceutical company focused on the research, development, manufacturing, and sale of prescription drugs. Headquartered in Lianyungang, China, it operates across key therapeutic areas including oncology, surgical anesthesia, endocrinology, cardiovascular disease, and anti-infective treatments. The company is particularly active in antineoplastic agents for cancer care and offers a broad portfolio of dosage forms such as tablets, capsules, injections, infusions, solutions, and biologic formulations.

Jiangsu Hengrui Pharmaceuticals Co., Ltd. places strong emphasis on innovative drug development, especially targeted therapies and other advanced treatments addressing complex diseases. Its products are used primarily in hospital and specialist clinical settings, serving physicians and healthcare institutions throughout China and in select international markets. Within the healthcare sector, the company plays a significant role as both a specialty and generic drug manufacturer, contributing to the availability of modern therapeutics and supporting the broader biopharmaceutical supply chain.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I JIANGSU HENGRUI PHARMACEUTICALS CO MED ENDAVU: Køb Jiangsu Hengrui Pharmaceuticals Co ($0BO) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Jiangsu Hengrui Pharmaceuticals Co, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.